CollPlant Biotechnologies Ltd.

NASDAQ
CLGN
paper.types.company
Altı ay boyunca karlılık: -61.2%
Temettü getirisi: 0%
Sektör: Healthcare

1.42 $

0 $ 0%
1.42 $
5.45 $

paper.min_max_per_year

Promosyon programı CollPlant Biotechnologies Ltd.

Gelişmiş program Basit grafik
Financial Markets by TradingView
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

Temel parametreler

IPO date
2018-01-30
ISIN
IL0004960188
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
bağlantı
Tüm parametreler

Seviye

Hafife alma
İsim Anlam Seviye
P/S 80.74 1
P/BV 3.09 5
P/E 0 0
Yeterlik
İsim Anlam Seviye
ROA -62.87 0
ROE -79.46 0
ROIC 0 0
Temettüler
İsim Anlam Seviye
Temettü getirisi 0 0
DSI 0 0
Ortalama temettü büyümesi 0 0
Görev
İsim Anlam Seviye
Debt/EBITDA -0.19 10
Debt/Ratio 0.1647 10
Debt/Equity 0.3895 10
Büyüme dürtüsü
İsim Anlam Seviye
Hasılat, % -91.56 0
Ebitda, % 230.88 10
EPS, % 71.95 8
Daha fazla ayrıntı

paper.price.prices

Fiyat Common.min. Common.max. Değiştirmek paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 1.42 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 1.73 $ 0 $ 0 $ -17.92 % 0 % 0 %
common.calendar.number_days.30d 1.93 $ 0 $ 0 $ -26.42 % 0 % 0 %
common.calendar.number_days.90d 2.44 $ 1.42 $ 4.54 $ -41.75 % 0 % 0 %
common.calendar.number_days.180d 3.66 $ 1.42 $ 4.54 $ -61.2 % 0 % 0 %
common.calendar.number_days.1y 5.25 $ 1.42 $ 5.45 $ -72.95 % 0 % 0 %
common.calendar.number_days.3y 7.84 $ 1.42 $ 12.99 $ -81.89 % 0 % 0 %
common.calendar.number_days.5y 9.46 $ 1.42 $ 24.25 $ -84.99 % 0 % 0 %
common.calendar.number_days.10y 1.42 $ 1.42 $ 24.25 $ +100 % 0 % 0 %
common.calendar.number_days.ytd 4.03 $ 1.42 $ 4.54 $ -64.76 % 0 % 0 %

Ana sahipler

Benzer şirketler

P/E & P/BVEV/Ebitda & Debt/Ebitda


Şirket yönetimi

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Yehiel Tal CEO & Director 751k 1952 (73 yıl)
Mr. Eran Rotem CPA Deputy CEO & CFO 528k 1968 (57 yıllar)
Prof. Oded Shoseyov Founder & Chief Scientist 384k 1956 (69 yıllar)
Mr. Oren Fahimipoor Vice President of Operations 212k 1982 (43 yıl)
Ms. Hadas Dreiher Horowitz Vice President of Human Resources N/A 1977 (48 yıllar)
Dr. Elana Gazal Vice President of Research & Development 379k 1975 (50 yıllar)

Şirket bilgileri

Adres: Israel, Rehovot, Weizmann Science Park - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.collplant.com

Şirket hakkında CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; Tel Aviv University; Sheba Medical Center; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.